McIlrath & Eck’s DexCom DXCM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-80
| Closed | -$6.22K | – | 954 |
|
2024
Q4 | $6.22K | Hold |
80
| – | – | ﹤0.01% | 713 |
|
2024
Q3 | $5.36K | Hold |
80
| – | – | ﹤0.01% | 735 |
|
2024
Q2 | $9.07K | Hold |
80
| – | – | ﹤0.01% | 622 |
|
2024
Q1 | $11.1K | Hold |
80
| – | – | ﹤0.01% | 581 |
|
2023
Q4 | $9.93K | Hold |
80
| – | – | ﹤0.01% | 560 |
|
2023
Q3 | $7.46K | Hold |
80
| – | – | ﹤0.01% | 586 |
|
2023
Q2 | $10.3K | Sell |
80
-6
| -7% | -$771 | ﹤0.01% | 556 |
|
2023
Q1 | $9.99K | Buy |
86
+6
| +8% | +$697 | ﹤0.01% | 554 |
|
2022
Q4 | $9.06K | Hold |
80
| – | – | ﹤0.01% | 553 |
|
2022
Q3 | $6K | Hold |
80
| – | – | ﹤0.01% | 604 |
|
2022
Q2 | $6K | Hold |
80
| – | – | ﹤0.01% | 586 |
|
2022
Q1 | $10K | Hold |
80
| – | – | ﹤0.01% | 523 |
|
2021
Q4 | $11K | Hold |
80
| – | – | ﹤0.01% | 522 |
|
2021
Q3 | $11K | Hold |
80
| – | – | ﹤0.01% | 506 |
|
2021
Q2 | $9K | Hold |
80
| – | – | ﹤0.01% | 530 |
|
2021
Q1 | $7K | Hold |
80
| – | – | ﹤0.01% | 531 |
|
2020
Q4 | $7K | Hold |
80
| – | – | ﹤0.01% | 476 |
|
2020
Q3 | $8K | Buy |
+80
| New | +$8K | ﹤0.01% | 417 |
|